What Researchers Did
Researchers conducted a health technology assessment to evaluate the safety, clinical effectiveness, and cost-effectiveness of hyperbaric oxygen therapy (HBOT) combined with standard wound care for diabetic foot ulcers, compared to standard wound care alone.
What They Found
The assessment included seven randomized controlled trials and one nonrandomized controlled trial evaluating hyperbaric oxygen therapy for diabetic foot ulcers. The provided abstract does not detail specific findings regarding the safety, clinical effectiveness, or cost-effectiveness of HBOT.
What This Means for Canadian Patients
This assessment helps inform healthcare decisions regarding the use of hyperbaric oxygen therapy for Canadian patients suffering from diabetic foot ulcers. Understanding the effectiveness and cost-effectiveness of HBOT can guide treatment options and potentially improve outcomes for those at risk of amputation.
Canadian Relevance
This health technology assessment was conducted in Ontario, Canada, and specifically examined the budget impact from the perspective of the Ministry of Health and Long-Term Care, making it highly relevant to the Canadian healthcare system.
Study Limitations
A potential limitation of such a health technology assessment could be the variability in quality or design among the included clinical trials.